Uterine Vein Injury LeftNCT06520969
Prevelance of Uterine Vein and Uterine Vein System Variations
A study testing Prevelance of Uterine Vein and Uterine Vein System Variations (anatomical study) in people with Uterine Vein Injury Left and Uterine Vein Injury Right, run by Istanbul University at 1 site in Turkey (Türkiye).
Trial summary
Contrary to the uterine arterial system, our knowledge about superficial and deep uterine vein prevalence and anatomic variations are limited. The present study aims to deepen and clarify our knowledge on superficial and deep uterine vein anatomy, prevalence and relationship with other neighbouring structures which… Read more about this study
- Who is it for?
- Any age, women onlyHealthy volunteers can take part
- Conditions the study is for
- Uterine Vein Injury Left, Uterine Vein Injury Right
- What is being tested?
- Prevelance of Uterine Vein and Uterine Vein System Variations (anatomical study)
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 100 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 30 Mar 2024to 30 Mar 2027
- Phase
- Interventional
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- Women only
- Healthy volunteers accepted
- Child, Adult, Older adult
Who may be able to join
- Endometrium and cervical cancer patients that will be operated -
Who cannot join
- Any women in whom uterine vascular anatomy that might be changed for a specific disease such as myomas, uterine infections, etc.
- -
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Turkey (Türkiye)1 site, 1 recruiting
- Recruiting
Istanbul University Medical Faculty Dept. of Obstet Gynecol, Division of Gynecologic Oncology
Istanbul, Istanbul / Turkey, 34093
Mustafa ALBAYRAK, MD, +905326871051, mustafaalbayrak@icloud.com
Yagmur MINARECI, MD, +905053574361, yagmurminareci@gmail.com
About this study
Contrary to the uterine arterial system, our knowledge about superficial and deep uterine vein prevalence and anatomic variations are limited. The present study aims to deepen and clarify our knowledge on superficial and deep uterine vein anatomy, prevalence and relationship with other neighbouring structures which may be helpful in uterine transplantation and radical hysterectomy operations.
Read the detailed description
Despite that two veins draining the uterus, superficial and deep, are described, their true anatomy, number, calibers, trajectories, relationships with sympathetic and parasympathetic nerves and internal iliac vasculature and ureters are quite limited. Additionally, variations of these vasculature are much less described. The aim of this study is to increase the our current knowledge about these anatomical information and also to calculate the prevalence of superficial and deep uterine veins which may potentially decrease the possible complications such as bleeding in uterine transplantation surgery and nerve sparing radical hysterectomy for cervical cancer.
- Being tested
- Prevelance of Uterine Vein and Uterine Vein System Variations (anatomical study)
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Prevelance of Uterine Vein and Uterine Vein System Variations (anatomical study)Other
Also called Single arm anatomical study describing the prevalance and anatomical variations of superficial and deep veins in endometrial and cervical cancer patients
Single arm anatomical study describing the prevalance and anatomical variations of superficial and deep veins in endometrial and cervical cancer patients
| Study group | Role | What they receive |
|---|---|---|
| prevalance and anatomical variations of superficial and deep veins | Other | Single arm anatomical study describing the prevalance and anatomical variations of superficial and deep veins in endometrial and cervical cancer patients Receives: Other: Prevelance of Uterine Vein and Uterine Vein System Variations (anatomical study) |
What is being measured
The primary outcome is the main question the study is designed to answer.
To describe the prevalence of uterine vein and uterine vein system variations
To describe the prevalence of uterine vein and uterine vein system variations
Measured: 2 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 Jul 2024
- Study start30 Mar 2024
- Primary completion30 Mar 2026 (estimated)
- Study completion30 Mar 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Uterine Vein Injury LeftStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Model description
- Endometrium and cervical cancer patients that will be operated in Istanbul University School of Medicine, Dept. of Obstetrics and Gynecology, Division of Oncology will be included. Anatomic details such as the presence, number of superficial and deep uterine veins, calibers, anatomical relationships with hypogastric arteries and veins, ureters, vesicouterine ligaments will be described systematically and bilaterally for every consenting women after pelvic spaces are opened before pelvic lypmhadenectomy and hysterectomy. All regarding information will be photographed for every patient bilaterally and recorded on data sheet.
- Masking
- None (open label)
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Istanbul University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Mustafa Albayrak, Istanbul University
- Investigators
- Samet Topuz, MD, Study director, Istanbul Univrsity
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06520969
- Sponsor's protocol ID
- 2248661
- Status last verified
- Jul 2024
- First submitted
- 20 Jul 2024
- Last updated
- 25 Jul 2024
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: all information stated in this document is open to to third parties whitout any limitations